title: Immunochemical detection of hepatic cocaine-protein adducts in mice.
abstract: Cocaine is capable of producing hepatic necrosis in laboratory animals and humans. Studies in mice indicate that N-oxidative metabolism of cocaine is required for hepatotoxicity and have suggested that toxicity may result from the adduction of proteins by cocaine-reactive metabolites. To aid in identifying protein targets for cocaine-reactive metabolites, an antibody was raised in rabbits immunized with cocaine linked via the tropane nitrogen to a carrier protein (bovine serum albumin). Hepatic proteins from cocaine-treated mice (ICR males, 50 mg of cocaine/kg of body weight, ip) and saline-treated controls were prepared from whole liver homogenate or following subcellular fractionation, and Western blot analyses of hepatic proteins using this antibody were conducted following one- and two-dimensional SDS-PAGE. Analysis of liver homogenate from cocaine-treated mice revealed major protein targets with approximate molecular masses of 20 kDa (pI = 6.0), 44 kDa (two proteins with pI's of 5.0 and 7.0), 52-54 kDa (pI = 4.5), and 64 kDa (pI = 5.5). These specific protein targets were shown to be localized in the mitochondria and microsomes. Several minor bands of immunoreactivity were also seen in mice treated with cocaine, but not in saline-treated controls. Pretreatment of mice with the P450 inhibitor SKF 525A diminished or eliminated the formation of these cocaine-protein adducts. Liver sections from cocaine-treated mice immunostained using the antibody indicated the presence of cocaine-adducted proteins in the centrilobular and midzonal regions of the lobule, corresponding to areas of hepatocyte swelling and necrosis. This study indicates that reactive metabolites from cocaine bind to discrete proteins in specific regions of the liver, consistent with a role for protein adduction in cocaine hepatotoxicity.
authors.affiliation: Center for Environmental & Human Toxicology and Department of Chemistry, University of Florida, Gainesville 32611, USA.
authors.forename: F M
authors.initials: FM
authors.lastname: Ndikum-Moffor
authors.forename: J W
authors.initials: JW
authors.lastname: Munson
authors.forename: N K
authors.initials: NK
authors.lastname: Bokinkere
authors.forename: J L
authors.initials: JL
authors.lastname: Brown
authors.forename: N
authors.initials: N
authors.lastname: Richards
authors.forename: S M
authors.initials: SM
authors.lastname: Roberts
mesh_terms: D000818:Animals; D000917:Antibody Formation; D015153:Blotting, Western; D003042:Cocaine / Q000737:chemistry / Q000276:immunology / Q000378:metabolism / Q000633:toxicity*; D005260:Female; D007120:Immunochemistry; D008099:Liver / Q000187:drug effects* / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D011506:Proteins / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism; D011817:Rabbits; D012709:Serum Albumin / Q000378:metabolism
chemical_list: D011506:Proteins; D012709:Serum Albumin; D003042:Cocaine